Evaluation of


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
03 2019
Historique:
received: 08 05 2018
accepted: 07 09 2018
pubmed: 22 9 2018
medline: 28 10 2019
entrez: 22 9 2018
Statut: ppublish

Résumé

5D3 is a new high-affinity murine monoclonal antibody specific for prostate-specific membrane antigen (PSMA). PSMA is a target for the imaging and therapy of prostate cancer.

Identifiants

pubmed: 30237212
pii: jnumed.118.214403
doi: 10.2967/jnumed.118.214403
pmc: PMC6424233
doi:

Substances chimiques

Antibodies, Monoclonal 0
Heterocyclic Compounds, 1-Ring 0
Indium Radioisotopes 0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid 1HTE449DGZ
Indium-111 E9NGC49E0T
Glutamate Carboxypeptidase II EC 3.4.17.21

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

400-406

Subventions

Organisme : NCI NIH HHS
ID : R01 CA157542
Pays : United States

Informations de copyright

© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Discov Med. 2010 Jan;9(44):55-61
pubmed: 20102687
Semin Nucl Med. 2016 Sep;46(5):462-78
pubmed: 27553471
J Nucl Med. 2003 Apr;44(4):610-7
pubmed: 12679407
J Nucl Med. 2005 May;46(5):850-8
pubmed: 15872360
Prostate. 2018 Aug;78(11):775-789
pubmed: 29717499
Bioconjug Chem. 2016 Jun 15;27(6):1447-55
pubmed: 27076393
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541
Rev Urol. 2004;6 Suppl 10:S13-8
pubmed: 16985927
Urol Oncol. 1995 Jan-Feb;1(1):29-37
pubmed: 21224087
Mod Pathol. 2012 Aug;25(8):1079-85
pubmed: 22460809
Urology. 1998 Oct;52(4):637-40
pubmed: 9763084
EJNMMI Res. 2015 Apr 29;5:28
pubmed: 25984435
Mol Imaging Biol. 2016 Jun;18(3):437-45
pubmed: 26920354
J Nucl Med. 2005 Apr;46(4):634-41
pubmed: 15809486
Clin Cancer Res. 2016 Jan 1;22(1):9-15
pubmed: 26728408
J Nucl Med. 2015 Apr;56(4):628-34
pubmed: 25722448
Q J Nucl Med Mol Imaging. 2015 Sep;59(3):241-68
pubmed: 26213140
Prostate. 2017 May;77(7):749-764
pubmed: 28247415
Anticancer Res. 1987 Sep-Oct;7(5B):927-35
pubmed: 2449118
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):989-998
pubmed: 29460025
Biomacromolecules. 2017 Jan 9;18(1):201-209
pubmed: 28001364
Prostate. 1997 Mar 1;30(4):232-42
pubmed: 9111600
J Nucl Med. 2009 Apr;50(4):606-11
pubmed: 19289418
Int J Cancer. 1998 May 29;76(5):738-48
pubmed: 9610734
J Nucl Med. 1993 Apr;34(4):689-94
pubmed: 8455089
Ann ICRP. 2002;32(3-4):5-265
pubmed: 14506981
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7195s-7200s
pubmed: 16203821
J Urol. 2018 Feb;199(2):370-377
pubmed: 28827104
Nat Biotechnol. 2005 Sep;23(9):1137-46
pubmed: 16151407
Cancer Res. 1997 Sep 1;57(17):3629-34
pubmed: 9288760
Clin Cancer Res. 2013 Sep 15;19(18):5182-91
pubmed: 23714732
J Nucl Med. 2017 Oct;58(10):1624-1631
pubmed: 28408529
J Nucl Med. 2018 May;59(5):747-748
pubmed: 29439016
J Nucl Med. 2005 Jun;46(6):1023-7
pubmed: 15937315
Cancer Biother Radiopharm. 2004 Dec;19(6):706-15
pubmed: 15665617
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):42-51
pubmed: 26318602
J Nucl Med. 2017 Jan;58(1):85-90
pubmed: 27765862
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268
pubmed: 28497198
Angew Chem Int Ed Engl. 2011 Sep 19;50(39):9167-70
pubmed: 21861274
Eur Urol. 2016 Dec;70(6):926-937
pubmed: 27363387
Phys Med Biol. 2011 Feb 7;56(3):721-33
pubmed: 21220845
Clin Cancer Res. 1999 Oct;5(10):2674-81
pubmed: 10537328
Curr Drug Targets. 2009 Feb;10(2):118-25
pubmed: 19199907
J Nucl Med. 2015 Feb;56(2):293-8
pubmed: 25613537
J Clin Oncol. 2007 Feb 10;25(5):540-7
pubmed: 17290063

Auteurs

Sangeeta Ray Banerjee (SR)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and sray9@jhmi.edu.

Vivek Kumar (V)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Ala Lisok (A)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Donika Plyku (D)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Zora Nováková (Z)

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.

Mary Brummet (M)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Bryan Wharram (B)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Cyril Barinka (C)

Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic.

Robert Hobbs (R)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Martin G Pomper (MG)

Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland; and.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH